Biomakers operates a centralized precision oncology platform that combines large‑scale genomic testing, clinical data aggregation, biobanking, and AI‑driven analytics across 18 Latin American countries. The integrated workflow delivers high‑quality molecular test results and tumor specimen storage, providing clinicians with actionable treatment insights and life‑science partners with diverse, real‑world genomic datasets to accelerate drug and diagnostic development.

Concr provides predictive modeling solutions using advanced computational methods derived from astrophysics to accurately forecast individual and cohort responses to cancer therapies. This technology enhances the design of clinical trials and improves the probability of success for novel cancer treatments, particularly in early-stage trials and rare cancers.

Daymark Health provides comprehensive, supportive cancer care coordination connecting patients with their oncology and primary care teams. The service offers 24/7 virtual and in-home support from nurse practitioners and social workers to manage symptoms, side effects, and urgent needs. This integrated approach breaks down barriers to care by coordinating appointments and connecting patients with necessary social and mental health resources.

One Health Company utilizes genomic testing and AI-driven precision medicine to identify targeted therapies for canine cancer, leveraging the largest proprietary cancer dataset from over 2,100 dogs. This approach addresses the high failure rate of traditional cancer treatments by providing veterinarians with data-driven insights to optimize treatment plans for individual dogs.

Provides personalized breast cancer risk assessments through a two-minute online questionnaire, followed by same- or next-day virtual consultations with specialized breast health practitioners. The platform facilitates early detection and prevention by ordering and scheduling necessary tests, such as mammograms and genetic screenings, while offering tailored care plans to reduce individual risk.

Health Universe provides secure workflow infrastructure enabling health systems to develop, test, and deploy HIPAA-compliant AI tools directly within clinical workflows. The platform facilitates the integration of proprietary or third-party AI models through secure sandboxes and FHIR/HL7 interoperability standards. This allows clinicians to receive real-time, AI-powered insights that automate tasks and enhance decision support, improving care quality and operational efficiency.

Provides a cloud-based platform, Archer, that automates the transfer of patient data from electronic health records (EHR) to electronic data capture (EDC) systems for clinical trials. By eliminating manual data transcription and source data verification, Archer reduces data transfer time by 96.5% during live oncology studies, ensuring fast, secure, and regulatory-compliant data collection.

Lumonus offers an AI-powered platform that optimizes oncology treatment planning and enhances care team collaboration. It automates administrative tasks, integrates disparate data, and provides clinical insights to improve physician efficiency and patient outcomes.

mPath Health offers a cloud-based automation platform that identifies individuals in need of preventive care services and connects them with personalized education and resources. This technology addresses the issue of over half of Americans not receiving guideline-recommended preventive care, ultimately improving healthcare quality metrics and patient outcomes.

OncoveryCare provides a fully virtual survivorship clinic that integrates physical and mental health services, personalized care planning, and community resource navigation for adult cancer survivors. Through telehealth visits and a digital portal, patients receive insurance‑covered, coordinated care from survivorship‑trained clinicians, along with education, peer support, and ongoing symptom monitoring.

Reimagine Care offers a virtual oncology care platform that combines an AI‑powered assistant, Remi, with a 24/7 team of oncology‑trained clinicians to provide continuous symptom monitoring and triage for cancer patients at home. The solution integrates patient‑generated data into provider workflows, helping keep patients out of emergency departments, improving outcomes, and extending care capacity without adding staff.

RISA Labs provides an AI‑driven platform that automates the end‑to‑end prior‑authorization workflow for oncology services, extracting data from EHRs, verifying eligibility, and generating medical‑necessity checklists. The system auto‑populates payer‑specific forms, submits requests via API, portal or e‑fax, and uses RPA bots and a dynamic rules engine to ensure compliance with payer guidelines and NCCN standards, reducing manual effort and claim denials.

Tono provides a telehealth platform that connects patients with specialized dermatology and endocrinology care through virtual consultations with leading medical professionals. This service addresses the challenge of accessing timely and high-quality specialty care, ensuring appointments are available within five days and improving patient outcomes and satisfaction.

Triomics is a generative AI platform that matches patients to clinical trials by analyzing health records and medical terminology. This technology alleviates the cognitive overload faced by healthcare staff, accelerating trial enrollment and improving oncology care operations.